New York University

New York University appears in the book as an institutional setting for psychedelic-related treatment and research, rather than as a location described through its buildings or campus. The references associate it with cancer-patient research and alcoholism treatment; a cited follow-up to its cancer trial examines patients’ experiences of psilocybin-assisted psychotherapy. The available account establishes the university’s place in this clinical history but does not provide details about the physical site or the treatment program for alcoholism.

Research and treatment

The book’s index links New York University with research involving cancer patients and with alcoholism treatment. These entries place the university in more than one strand of psychedelic medicine, though the index alone does not specify the methods or outcomes of the alcoholism work. For cancer research, a follow-up study is identified as an interpretative phenomenological analysis of patient experiences in psilocybin-assisted psychotherapy. This points to attention not only to clinical outcomes but also to how participants understood and described treatment.

The cancer-trial record

A citation for the follow-up analysis appears alongside the book’s discussion of cancer research. Its focus on patient experience distinguishes it from a simple catalogue of clinical results: the study treats the participants’ accounts as evidence to be interpreted. The citation confirms a research connection between New York University and this body of work, while the available material does not establish further details about the study’s design, findings, or the university’s precise role in conducting it.

Place in the book’s account

The references to New York University recur across several page ranges, particularly in connection with cancer-patient research. This recurrence gives the institution a continuing, if briefly documented, presence in the book’s account of psychedelic treatment. New York University is thus presented through its research associations: an academic institution linked to clinical investigation, with cancer-patient work most distinctly represented by a study examining the lived experience of psilocybin-assisted psychotherapy.